Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;11(10):682-689.
doi: 10.14740/jocmr3963. Epub 2019 Oct 4.

Management of Esophageal Achalasia in Quebec

Catherine Pouyez  1 , Elissaveta Neshkova  1 , Daniel von Renteln  1 , Mickael Bouin  1
Affiliations

Management of Esophageal Achalasia in Quebec

Catherine Pouyez et al. J Clin Med Res. 2019 Oct.

Abstract

Background: Esophageal achalasia is a defective relaxation of the lower esophageal sphincter with a loss of esophageal peristalsis causing dysphagia. Treatment can be Heller myotomy, pneumatic balloon dilation, Botox injections, peroral endoscopic myotomy (POEM) or medical. The main objective of the study was to measure the extent of post-treatment dysphagia depending on the type of treatment.

Methods: This was a retrospective study conducted at the Centre Hospitalier de l'Universite de Montreal (CHUM) between 2011 and 2017. All patients with manometric diagnostic of achalasia in our department were included. Data were collected with the electronic health record and a standardized post-treatment telephone survey to evaluate the extent of dysphagia and the use of proton pump inhibitor (PPI).

Results: A total of 169 patients were included. The most frequent treatments were Heller myotomy (60%), Botox injection (18%) and endoscopic balloon dilation (16%). There was a significant difference in the management of patients treated at the CHUM and outside the CHUM for the frequency of pneumatic dilation (28 vs. 7%; P = 0.001) and Heller myotomy (49 vs. 69%; P = 0.02). An Eckardt score ≤ 3 was found in 80% of patients. No significant score difference was found between the CHUM and outside CHUM groups or between the different treatments. The post-treatment use of PPI was of 49% and was not significantly different depending on the site or the type of treatment.

Conclusion: Heller myotomy stays the most frequent treatment, especially outside our tertiary center. The rate of post-treatment dysphagia is low no matter the treatment choice. The use of PPI stays frequent regardless of the management site or the type of treatment used.

Keywords: Eckardt score; Esophageal achalasia; Management in Quebec.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1
Figure 1
Age distribution of patients with esophageal achalasia.
Figure 2
Figure 2
Eckardt score distribution after treatment of esophageal achalasia.
Figure 3
Figure 3
Comparison of post-treatment Eckardt score depending on the type of treatment for esophageal achalasia.
Figure 4
Figure 4
Comparison of post-treatment Eckardt score depending on the delay after the treatment for esophageal achalasia.
Figure 5
Figure 5
Percentage of patients taking proton pump inhibitor depending on the type of treatment for esophageal achalasia.
Figure 6
Figure 6
Percentage of patients taking proton pump inhibitor depending on the delay after the treatment for esophageal achalasia.
Figure 7
Figure 7
Percentage of patients needing a second treatment depending on the type of treatment for esophageal achalasia.
Figure 8
Figure 8
Comparison of the management of patients treated at the CHUM vs. outside CHUM for esophageal achalasia.
Figure 9
Figure 9
Comparison of post-treatment Eckardt score depending on the site of treatment for esophageal achalasia.
Figure 10
Figure 10
Percentage of patients taking proton pump inhibitor depending on the site of treatment for esophageal achalasia.
See this image and copyright information in PMC

References

    1. Patel DA, Lappas BM, Vaezi MF. An overview of achalasia and its subtypes. Gastroenterol Hepatol (N Y) 2017;13(7):411–421. - PMC - PubMed
    1. Stavropoulos SN, Friedel D, Modayil R, Parkman HP. Diagnosis and management of esophageal achalasia. BMJ. 2016;354:i2785. doi: 10.1136/bmj.i2785. - DOI - PubMed
    1. Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–1852. doi: 10.1001/jama.2015.2996. - DOI - PubMed
    1. Moonen A, Boeckxstaens G. Current diagnosis and management of achalasia. J Clin Gastroenterol. 2014;48(6):484–490. doi: 10.1097/MCG.0000000000000137. - DOI - PubMed
    1. Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE, Patti MG. et al. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31(9):doy071. doi: 10.1093/dote/doy071. - DOI - PubMed

LinkOut - more resources